X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Dr. Reddys with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs J.B.CHEMICALS - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB J.B.CHEMICALS DR. REDDYS LAB/
J.B.CHEMICALS
 
P/E (TTM) x 23.2 17.3 134.1% View Chart
P/BV x 3.2 2.2 144.9% View Chart
Dividend Yield % 0.7 0.5 138.6%  

Financials

 DR. REDDYS LAB   J.B.CHEMICALS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
J.B.CHEMICALS
Mar-18
DR. REDDYS LAB/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs2,875363 791.8%   
Low Rs1,888255 740.4%   
Sales per share (Unadj.) Rs930.2169.1 550.0%  
Earnings per share (Unadj.) Rs117.416.6 707.4%  
Cash flow per share (Unadj.) Rs185.823.4 793.3%  
Dividends per share (Unadj.) Rs20.002.00 1,000.0%  
Dividend yield (eoy) %0.80.6 129.8%  
Book value per share (Unadj.) Rs844.4172.5 489.5%  
Shares outstanding (eoy) m166.0783.57 198.7%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x2.61.8 140.1%   
Avg P/E ratio x20.318.6 108.9%  
P/CF ratio (eoy) x12.813.2 97.1%  
Price / Book Value ratio x2.81.8 157.4%  
Dividend payout %17.012.0 141.4%   
Avg Mkt Cap Rs m395,49625,827 1,531.3%   
No. of employees `00022.03.8 582.3%   
Total wages/salary Rs m33,5622,511 1,336.6%   
Avg. sales/employee Rs Th7,032.83,747.4 187.7%   
Avg. wages/employee Rs Th1,527.9665.7 229.5%   
Avg. net profit/employee Rs Th887.7367.8 241.4%   
INCOME DATA
Net Sales Rs m154,48214,135 1,092.9%  
Other income Rs m3,375366 922.6%   
Total revenues Rs m157,85714,501 1,088.6%   
Gross profit Rs m31,7822,178 1,459.0%  
Depreciation Rs m11,348570 1,991.9%   
Interest Rs m88935 2,547.3%   
Profit before tax Rs m22,9201,940 1,181.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,858552 698.5%   
Profit after tax Rs m19,5001,387 1,405.7%  
Gross profit margin %20.615.4 133.5%  
Effective tax rate %16.828.5 59.1%   
Net profit margin %12.69.8 128.6%  
BALANCE SHEET DATA
Current assets Rs m111,10110,470 1,061.1%   
Current liabilities Rs m58,9732,749 2,145.3%   
Net working cap to sales %33.754.6 61.8%  
Current ratio x1.93.8 49.5%  
Inventory Days Days7955 143.8%  
Debtors Days Days9478 121.3%  
Net fixed assets Rs m101,2455,811 1,742.3%   
Share capital Rs m830167 496.7%   
"Free" reserves Rs m139,40614,248 978.4%   
Net worth Rs m140,23614,416 972.8%   
Long term debt Rs m22,0000-   
Total assets Rs m224,65617,649 1,272.9%  
Interest coverage x26.856.6 47.3%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.70.8 85.9%   
Return on assets %9.18.1 112.6%  
Return on equity %13.99.6 144.5%  
Return on capital %14.913.7 109.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m88,6736,164 1,438.6%   
Fx outflow Rs m19,1041,334 1,431.6%   
Net fx Rs m69,5694,829 1,440.5%   
CASH FLOW
From Operations Rs m28,7041,231 2,332.7%  
From Investments Rs m-7,727-208 3,713.1%  
From Financial Activity Rs m-21,326-595 3,583.0%  
Net Cashflow Rs m-314427 -73.5%  

Share Holding

Indian Promoters % 25.5 55.4 46.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 5.4 3.4 159.3%  
FIIs % 35.3 3.9 905.1%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 37.0 41.4%  
Shareholders   75,885 30,437 249.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  FDC LTD.  JUBILANT LIFE SCIENCES  BIOCON   

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; Metal & Automobile Stocks Slip(12:30 pm)

Share markets in India are presently trading on a negative note. Barring finance sector, all sectoral indices are trading in red with stocks in the metal sector.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jul 18, 2019 02:15 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS